Kolosis BIO
Collin Begley has a diverse background in the medical device industry, with experience in leadership roles at companies such as Kolosis BIO, Orthofix, NuVasive, and Cook Medical. Collin has a strong track record of building successful international sales and marketing strategies, as well as extensive experience in biologics and orthobiologics. Collin holds a JD from Indiana University Bloomington and a Bachelor of Arts in International Politics from Brigham Young University.
Kolosis BIO
Kolosis BIO is a leading provider of innovative surgical products primarily in the spine and orthopedic market. As a pure-play biologics company, Kolosis exclusively partners with MTF Biologics to offer superior quality allograft technologies that are backed by MTF’s proprietary processing methods. Kolosis is dedicated to driving innovation and expanding its product offerings, pushing the boundaries of science to enhance patient outcomes.